Inverted Papilloma, also known as inverted squamous cell papilloma, is related to urinary bladder inverted papilloma and urinary tract papillary transitional cell benign neoplasm. An important gene associated with Inverted Papilloma is FSCN1 (Fascin Actin-Bundling Protein 1), and among its related pathways/superpathways are Cell Cycle, Mitotic and Cellular Senescence. The drugs Bevacizumab and Cetuximab have been mentioned in the context of this disorder. Affiliated tissues include endothelial and breast, and related phenotypes are growth/size/body region and neoplasm